Sanofi Stock

Sanofi Gross Margin

The Gross Margin of Sanofi (SAN.PA) as of Aug 25, 2026 is 72.07 %. In the previous year, Gross Margin was 70.21 % — a change of 2.65% (higher).

Gross Margin

72.07 %

YoY

2.65%

Last updated:

Gross Margin of Sanofi is 2026 72.07 % . Gross Margin of Sanofi was 2025 70.21 % . It decreases by 2.65% higher compared to the previous year.

For Sanofi, the gross margin of 72.1% is up versus 68.7% a few years ago.

The Sanofi Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
68.27 EUR
Jan 1, 2019
68.18 EUR
Jan 1, 2020
67.60 EUR
Jan 1, 2021
68.73 EUR
Jan 1, 2022
70.55 EUR
Jan 1, 2023
69.30 EUR
Jan 1, 2024
70.21 EUR
Jan 1, 2025
72.07 EUR
The Sanofi Gross Margin history
YEARGross MarginYoY
72.07 %+2.65%
70.21 %+1.30%
69.30 %-1.77%
70.55 %+2.65%
68.73 %+1.66%
67.60 %-0.84%
68.18 %-0.14%
68.27 %-0.19%
68.40 %-1.10%
69.16 %+0.70%
68.68 %+0.95%
68.03 %+10,038.28%
0.67 %-3.03%
0.69 %+0.43%
0.69 %-5.34%
0.73 %-2.13%
0.74 %-0.23%
0.75 %+0.63%
0.74 %-0.26%
0.74 %
Access this data via the Eulerpool API

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

Gross Margin of Sanofi is 72.07 % in 2026.

Gross Margin of Sanofi changed from 70.21 % to 72.07 %, representing a 2.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Sanofi since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Sanofi with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Sanofi

All Key Metrics — Sanofi